MedWatch

Newly formed biotech company with fresh capital

The Swedish company Galecto Biotech, lead by Dane Hans Schambye, has brought two additional investors on board, one of which signals the first investment from a new investment fund.

Søren Lemonius, partner in Sunstone Capital. | Foto: Sunstone Capital/ PR

Seed Capital and Sunstone Capital now join the list of investors in the newly formed biotech company Galecto Biotech. Novo A/S and Merck Serono Ventures have already posted capital in the company, which is headed by Dane Hans Schambye.

With the new investors, the total investment capital doubles to GBP 10 million.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier